Immune Reconstitution Syndrome with Initiation of Treatment of HBV/HIV Co-infection: Activity Flare associated with E antigen Seroconversion.

Immune reconstitution syndrome is a recognized complication with initiation of highly active antiretroviral therapy for acquired immune deficiency syndrome patients co-infected with hepatitis B. Hepatitis B flares are seen in 20%-25% of patients after initiation of highly active antiretroviral therapy, an estimated 1%-5% of whom develop clinical hepatitis. We present a case of highly active antiretroviral therapy initiation for HIV that led to a flare of HBV activity despite antiviral therapy directed towards both. Liver biopsy and longitudinal serologic evaluation lend support to the hypothesis that the flare in activity was representative of IRIS. Importantly, we document eAg/eAb seroconversion with the IRIS phenomenon.

[1]  Gérard Krause,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[2]  J. Hayashi,et al.  The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[3]  J. Hayashi,et al.  Hepatitis B virus-related immune reconstitution inflammatory syndrome in two patients coinfected with human immunodeficiency virus diagnosed with a liver biopsy. , 2014, Internal medicine.

[4]  S. Chakrabarti,et al.  Molecular Characterization of HBV Strains Circulating among the Treatment-Naive HIV/HBV Co-Infected Patients of Eastern India , 2014, PloS one.

[5]  A. Petrescu,et al.  Toxoplasmosis: a rare cause of IRIS in HIV infected patients. Case series , 2013, BMC Infectious Diseases.

[6]  E. Poveda,et al.  Hepatitis B in HIV-infected patients. , 2013, Clinics in liver disease.

[7]  S. Lewin,et al.  Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand , 2012, AIDS Research and Therapy.

[8]  M. Mosunjac,et al.  Development of fatal acute liver failure in HIV-HBV coinfected patients. , 2010, World journal of gastroenterology.

[9]  L. Haddow,et al.  Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  S. Lewin,et al.  Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy. , 2009, The Journal of infectious diseases.

[11]  M. French.  HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  V. Soriano,et al.  Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. , 2008, AIDS.

[13]  Chien-Jen Chen,et al.  Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. , 2006, Gastroenterology.

[14]  G. Foster,et al.  National Health and Nutrition Examination Survey , 2005 .

[15]  D. Milich,et al.  Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection , 2003, Hepatology.

[16]  F. Wit,et al.  Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy. , 2002, The Journal of infectious diseases.

[17]  D. Cooper,et al.  The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. , 1991, The Journal of infectious diseases.

[18]  S. Hadler,et al.  Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. , 1991, The Journal of infectious diseases.